This study is looking at how well a special dye, indocyanine green (ICG), helps surgeons remove bone or soft tissue sarcomas. ICG is used during surgery to see if all the tumor has been removed. Researchers want to see if the dye's results during surgery match what doctors find later when they examine the removed tissue. You might be able to join if you are 18 or older, have a confirmed bone or soft tissue sarcoma, and are having surgery to remove it. You cannot join if you have chronic kidney disease or are allergic to dyes. The study aims to enroll 50 participants, but its current recruitment status is unclear.

Study design

This is an observational study, meaning researchers will watch and collect information without giving new treatments. It plans to include 50 participants.

What's involved

You would receive an ICG infusion before your scheduled surgery, and your medical records will be reviewed.

Compensation

Not stated in the trial record.

Follow-up

The primary endpoint, which is the accuracy of ICG fluorescence, is measured at Baseline (during surgery).

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.